Companies / India
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Indian Firms Scavenging US Assets
November 2006 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Indian drugmakers are exploiting Chapter 11 bankruptcy laws in the US to pick up R&D assets, as the local pharmaceutical environment slowly shifts its focus from generics to innovative medicines. BMI believes that targeting companies under bankruptcy protection can be an excellent, albeit risky, way of acquiring R&D facilities at bargain